Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1). (Q37106467)
Jump to navigation
Jump to search
scientific article published on 05 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1). |
scientific article published on 05 April 2013 |
Statements
1 reference
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1). (English)
1 reference
Julio Rosenstock
1 reference
Matthew C Riddle
1 reference
Thomas Forst
1 reference
Ronnie Aronson
1 reference
Leobardo Sauque-Reyna
1 reference
Elisabeth Souhami
1 reference
Louise Silvestre
1 reference
Lin Ping
1 reference
Identifiers
1 reference